Whitehawk Therapeutics Inc (NASDAQ: WHWK) is a Healthcare company (Biotechnology) with a market capitalization of $182M. The Maz Rating grades it against the other companies in its sector.
Whitehawk Therapeutics Inc's current Maz Rating and its five factor grades are for members: log in to see them.
At $3.08, Whitehawk Therapeutics Inc trades at 1.8x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -55.7%, return on invested capital of -54.8% and a free cash flow yield of -40.5%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 16.47. Over the past 52 weeks the share price ranged from $1.97 to $5.50, with a beta of 0.81.
Whitehawk Therapeutics Inc does not currently pay a dividend.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.